Basilea Pharmaceutica AG Share Price
Stocks
BSLN
CH0011432447
Biotechnology & Medical Research
OTC Markets Traded|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 51.90 CHF | -0.57% |
|
-1.14% | -4.94% |
| Market Cap | 65Cr 80Cr 70Cr 60Cr 112.41Cr 7.66TCr 114.44Cr 766.05Cr 299.94Cr 3.8TCr 301.25Cr 294.66Cr 13TCr | P/E 2026 * |
13.9x | P/E 2027 * | 18.2x |
|---|---|---|---|---|---|
| Enterprise Value | 49Cr 61Cr 53Cr 46Cr 86Cr 5.86TCr 88Cr 585.79Cr 229.36Cr 2.91TCr 230.37Cr 225.32Cr 9.78TCr | EV / Sales 2026 * |
1.88x | EV / Sales 2027 * | 1.62x |
| Free-Float |
91.73% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Basilea Pharmaceutica AG
| 1 day | -0.57% | ||
| 1 week | -1.33% | ||
| Current month | -2.81% | ||
| 1 month | -1.89% | ||
| 3 months | -5.29% | ||
| 6 months | -5.29% | ||
| Current year | -5.12% |
| 1 week | 51.5 |  | 53.2 |
| 1 month | 50.4 | | 56.3 |
| Current year | 47.8 | | 59.2 |
| 1 year | 44.7 | | 59.2 |
| 3 years | 32 | | 59.7 |
| 5 years | 29.55 | | 59.7 |
| 10 years | 29.28 | | 95.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Veitch
CEO | Chief Executive Officer | 61 | 19/04/2018 |
Adesh Kaul
DFI | Director of Finance/CFO | 52 | 10/04/2019 |
Gerrit Hauck
CTO | Chief Tech/Sci/R&D Officer | 62 | 01/05/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Werner
BRD | Director/Board Member | 70 | 29/11/2011 |
| Chairman | 71 | 09/04/2013 | |
Nicole Onetto
BRD | Director/Board Member | 73 | 27/04/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 29/05/26 | Sell | -400 | 0.0030% | |||
| 25/02/26 | Fiscal year | 1,500 | 0.0113% | |||
| 20/02/26 | Sell | 600 | 0.0045% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.38% | -1.33% | -10.52% | +18.36% | 80Cr | |
| -0.86% | +3.25% | -1.08% | +12.00% | 4.94TCr | |
| -2.44% | +11.66% | +24.99% | +3.82% | 3.91TCr | |
| -1.75% | -0.79% | +403.72% | +615.18% | 4.09TCr | |
| -2.49% | -3.98% | +3.92% | +46.08% | 3.58TCr | |
| -1.74% | +8.42% | +8.85% | +48.87% | 3.05TCr | |
| -2.32% | -3.46% | - | - | 1.66TCr | |
| -1.61% | -5.45% | +33.10% | +124.60% | 1.61TCr | |
| -1.39% | -1.57% | -3.56% | -35.10% | 1.28TCr | |
| -0.06% | +3.22% | +1.81% | +9.52% | 1.37TCr | |
| Average | -1.55% | +5.22% | +51.25% | +93.70% | 2.56TCr | |
| Weighted average by Cap. | -1.72% | +6.70% | +76.68% | +128.49% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 26Cr 33Cr 28Cr 24Cr 46Cr 3.11TCr 47Cr 311.26Cr 121.87Cr 1.55TCr 122.4Cr 119.72Cr 5.2TCr | 27Cr 33Cr 29Cr 25Cr 46Cr 3.17TCr 47Cr 316.65Cr 123.98Cr 1.57TCr 124.53Cr 121.8Cr 5.29TCr |
| Net income | 5.16Cr 6.39Cr 5.55Cr 4.76Cr 8.96Cr 610.36Cr 9.12Cr 61Cr 24Cr 303.14Cr 24Cr 23Cr 1.02TCr | 3.92Cr 4.86Cr 4.23Cr 3.62Cr 6.82Cr 464.44Cr 6.94Cr 46Cr 18Cr 230.67Cr 18Cr 18Cr 775.71Cr |
| Net Debt | -15Cr -19Cr -16Cr -14Cr -26Cr -1.8TCr -27Cr -180.26Cr -71Cr -895.04Cr -71Cr -69Cr -3.01TCr | -21Cr -26Cr -23Cr -20Cr -37Cr -2.52TCr -38Cr -251.67Cr -99Cr -1.25TCr -99Cr -97Cr -4.2TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/26/31 | CHF 51.90 | -0.57% | 11,517 |
| 30/26/30 | CHF 52.20 | -0.38% | 11,668 |
| 29/26/29 | CHF 52.40 | +1.16% | 22,475 |
| 28/26/28 | CHF 51.80 | -1.15% | 22,623 |
| 27/26/27 | CHF 52.40 | -0.38% | 22,187 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BSLN Stock
Select your edition
All financial news and data tailored to specific country editions
